Cord Blood America finalizes agreement to process and store cord blood specimens for BioCells

Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has finalized an agreement to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.

BioCells is the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD) and 12 locations throughout that country, plus it recently expanded to both Uruguay and Paraguay.  "BioCells is an outstanding firm and we are delighted to finalize this agreement," said Matthew Schissler, Cord Blood America co-founder and CEO.

Cord Blood America recently opened its 17,000 square foot stem cell laboratory and headquarters in Las Vegas, near the city's international airport.  "This transaction is an excellent example of how we are diversifying our revenue model with our new, increased storage capacity," Mr. Schissler said.